Q-omics provides the consensus-scored MIR4515 profile across patient tissues and cancer cell-line models. MIR4515 expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in LUSC. Among the 18 cancer types available for tumor–normal comparison, MIR4515 is differentially expressed in 2, with the highest sampling consensus in KICH. Additionally, MIR4515 RNA expression shows 3,278 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LUSC, KICH, and STAD as cancer lineages where MIR4515 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR4515 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR4515 survival associations across molecular data types. MIR4515 RNA expression shows survival associations in the most cancer types (6). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR4515 RNA expression–survival associations across cancer types. High MIR4515 expression shows unfavorable associations in LUSC, LIHC, THYM, GBM and KIRP, but favorable associations in SKCM. The LUSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .008). Together, the overview and detailed table identify LUSC as the clearest survival context for MIR4515 RNA expression.
This table summarizes MIR4515 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for MIR4515. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR4515 shows lower tumor expression in THCA and higher tumor expression in KICH. The KICH box plot shows higher MIR4515 RNA expression in tumor versus normal tissue (log2 FC = +0.540, t-test p < 0.001).
This table shows molecular features associated with MIR4515 in patient tissues and cancer cell lines. In patient samples, MIR4515 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
